Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

soretolide

Known as: 2,6-dimethylbenzamide-N-(5-methyl-3-isoxazole) 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2012
Review
2012
A significant number of cases of clinical canine epilepsy remain difficult to control in spite of the applied treatment. At the… Expand
  • table 1
  • table 2
  • table 3
Is this relevant?
Review
2009
Review
2009
This review briefly summarizes the information on the molecular mechanisms of action, pharmacokinetic profiles and drug… Expand
Is this relevant?
Review
2009
Review
2009
  • J. Luszczki
  • Pharmacological reports : PR
  • 2009
  • Corpus ID: 4724853
This review briefly summarizes the information on the molecular mechanisms of action, pharmacokinetic profiles and drug… Expand
Is this relevant?
Review
2001
Review
2001
  • M. O. Fatope
  • Current opinion in investigational drugs
  • 2001
  • Corpus ID: 10089057
Laboratoires Biocodex is developing soretolide (D-2916) as a potential treatment for epilepsy. It is currently in phase II trials… Expand
Is this relevant?
2001
2001
Laboratoires Biocodex is developing soretolide (D-2916) as a potential treatment for epilepsy. It is currently in phase II trials… Expand
Is this relevant?
Review
2000
Review
2000
  • K. Jain
  • Expert opinion on investigational drugs
  • 2000
  • Corpus ID: 8495458
This article evaluates rufinamide, a new anti-epileptic drug (AED) in Phase III development. This review is done against the… Expand
Is this relevant?
Review
1999
Review
1999
The Fourth Eilat Conference on New Antiepileptic Drugs (AEDs) was held at the Royal Beach Hotel, Eilat, Israel, from 6th to 10th… Expand
Is this relevant?
Review
1999
Review
1999
  • Walker, Sander
  • Expert opinion on investigational drugs
  • 1999
  • Corpus ID: 26970506
Epilepsy represents the most common serious neurological disorder, with a prevalence of 0.4 - 1%. Approximately 30% of patients… Expand
Is this relevant?
1991
1991
  • L. Sander
  • Epilepsy research. Supplement
  • 1991
  • Corpus ID: 31477401
New antiepileptic drugs (AEDs) are necessary for people with chronic epilepsy and for improving upon established AEDs as first… Expand
  • table 1
  • table 2
  • table 3
Is this relevant?